WHO ICTRP trial

Akarakarabha vati in the management of erectile dysfunction

CTRI/2021/02/031047 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2021/02/031047
Public title Akarakarabha vati in the management of erectile dysfunction
Scientific title An open lable single arm clinical study on the effectiveness of Akarakarabha vati in the management of Klaibya (Erectile dysfunction)
Primary sponsor Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 2/ Phase 3
Countries India
Conditions Health Condition 1: N529- Male erectile dysfunction, unspecified
Interventions Intervention1: Vati - Akarakarabha vati : Dose - 500 mg twice a day after food Anupana - warm milk Duration - 30 days Control Intervention1: Nil: Nil
Registration date May 2, 2021
Target size 20
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations